jjzz国产-正在播放国产91-福利视频在线-台湾妹中文娱乐网-半推半就一ⅹ99av-每日更新av-色综合99久久久无码国产精品-www在线观看视频-亚洲女人18毛片水真多-求欧美精品网址-国产一区二区91-综合网天天-我的丝袜美腿尤物麻麻-欲奴性猛交3未删减-在线看一区二区-亚州一级-国产成人在线一区-顶臀精品视频www-欧美在线一区二区三区四区-精品二区视频-粉嫩av渣男av蜜乳av-国产香蕉一区-www.五月天com-中国女人69xxxx-欧美国产视频在线观看-久久亚洲伦理-久久精品一本

資料下載

Data download

當前位置：首頁資料下載matriksbiotek2024年價格表-上海起發

matriksbiotek2024年價格表-上海起發

發布時間：2024/3/4點擊次數：448

matriksbiotek2024年價格表

Matriks Biotek專門生產針對抗體藥的ELISA試劑盒，用于檢測抗體藥的體內含量或因用于產生的針對相應抗體藥的抗體的體內含量。Matriks Biotek®, SHIKARI®和KLONART®為Matriks生物技術公司注冊的產品商標。其產品達到ISO 13485 & CE IVD標準。

MatriksBiote抗體藥是一類相對新型的生物制劑。檢測抗體藥及其抗體水平在治療和個性化用藥上具有重要意義。大量的臨床和制藥公司都在致力于抗體藥物的濃度水平和療效的研究。

特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用！！！本次報價有效時間為2024年1月8日---2024年12月14日。

貨號品名規格價格品牌貨期價格來源
ABA-FD-OREAbatacept (Orencia®) Free drug96T13541.38 matriksbiotek3-4周上海起發
ABA-QLS-OREAbatacept (Orencia®) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
ABA-QNS-OREAbatacept (Orencia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
ADA-FD-HUMAdalimumab (Humira®) Free drug96T11834.48 matriksbiotek3-4周上海起發
ADA-QLS-HUMAdalimumab (Humira®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
ADA-QNFT-HUMAdalimumab (Humira®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-QNS-HUMAdalimumab (Humira®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ADA-SPEC-ADAAdalimumab (Humira®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-FD-SENS-EYLAflibercept (Eylea®) Free drug96T12289.66 matriksbiotek3-4周上海起發
AFL-QLS-EYLAflibercept (Eylea®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
AFL-QNS-EYLAflibercept (Eylea®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
ATE-FD-TECAtezolizumab (Tecentriq®) Free drug96T12289.66 matriksbiotek3-4周上海起發
ATE-QLS-TECAtezolizumab (Tecentriq®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
BEV-FD-AABevacizumab (Avastin®) Free drug96T11834.48 matriksbiotek3-4周上海起發
CAN-FD-ILACanakinumab (Ilaris®) Free drug96T12289.66 matriksbiotek3-4周上海起發
CAN-QLS-ILACanakinumab (Ilaris®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
CAN-QNS-ILACanakinumab (Ilaris®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
DAR-FD-DARDaratumumab (Darzalex®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DAR-QLS-DARDaratumumab (Darzalex®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
DEN-QNS-PRODenosumab (Prolia®) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
DUR-FD-IMFDurvalumab (Imfinzi®) Free drug96T12289.66 matriksbiotek3-4周上海起發
DUR-QLS-IMFDurvalumab (Imfinzi®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
ETA-FD-ENBEtanercept (Enbrel®) Free drug96T11834.48 matriksbiotek3-4周上海起發
EVO-FD-REPEvolocumab (Repatha® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
EVO-QLS-REPEvolocumab (Repatha® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
INF-FD-REMIInfliximab (Remicade®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-FD-REMSInfliximab (Remsima®) Free drug96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMIInfliximab (Remicade®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QLS-REMSInfliximab (Remsima®) Antibody screening - Qualitative96T11834.48 matriksbiotek3-4周上海起發
INF-QNFT-REMIInfliximab (Remicade®) Antibody screening - Free/Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNFT-REMSInfliximab (Remsima®) Antibody screening - Total semiquantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMIInfliximab (Remicade®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-QNS-REMSInfliximab (Remsima®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
INF-SPEC-INFInfliximab (Remicade®) Free drug / Specific96T12289.66 matriksbiotek3-4周上海起發
NIV-FD-OPDNivolumab (Opdivo®) Free drug96T12289.66 matriksbiotek3-4周上海起發
PAL-FD-SYNPalivizumab (Synagis® ) Free drug96T13541.38 matriksbiotek3-4周上海起發
PAL-QLS-SYNPalivizumab (Synagis® ) Antibody screening - Qualitative96T13541.38 matriksbiotek3-4周上海起發
PAL-QNS-SYNPalivizumab (Synagis® ) Antibody screening - Quantitative96T13541.38 matriksbiotek3-4周上海起發
PEM-FD-KEYPembrolizumab (Keytruda®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RAN-FD-LUCRanibizumab (Lucentis®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-FD-RMRituximab (Rituxan®, Mabthera®) Free drug96T12289.66 matriksbiotek3-4周上海起發
RIT-QLS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
RIT-QNS-RMRituximab (Rituxan®, Mabthera®) Antibody screening - Quantitative96T12289.66 matriksbiotek3-4周上海起發
SEC-FD-VERSecukinumab (Cosentyx® , Verxant®) Free drug96T12289.66 matriksbiotek3-4周上海起發
SEC-QLS-VERSecukinumab (Cosentyx® , Verxant®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
TOC-QNS-ACTTocilizumab (Actemra®) Antibody screening - Quantitative96T11834.48 matriksbiotek3-4周上海起發
TRA-FD-HHTrastuzumab (Herceptin®, Herclon®) Free drug96T11834.48 matriksbiotek3-4周上海起發
UST-QLS-STEUstekinumab (Stelara®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發
VED-FD-ENTVedolizumab (Entyvio®) Free drug96T12289.66 matriksbiotek3-4周上海起發
VED-QLS-ENTVedolizumab (Entyvio®) Antibody screening - Qualitative96T12289.66 matriksbiotek3-4周上海起發


（*此為部分產品價格完整價格請下載文件）


關鍵詞：matriksbiotek、Matriks Biotek®、KLONART®、SHIKARI®、ELISA試劑盒

文件下載